Otsuka Pharma Germany News and Activities

Otsuka Pharma Germany is owned by Otsuka Holdings.

Otsuka Holdings is one of the...

• Forbes Global 2000 (#654);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Otsuka Holdings is a company listed under the stock ticker 4578 (JP).

Otsuka Holdings has a direct presence in 11 countries.

Otsuka Holdings has 23 subsidiaries including Araris Biotech, Cambridge Isotope Laboratories and Interpharma.

They are in:

• Pharmaceuticals46%
• Medical Equipment29%
• Other25%

View the org chart displaying its 2 main executives

Most searched biographies at Otsuka Pharma Germany

• Rainer Rapkowitz, Managing Director
• Benedikte Sabina Kühne, Head of Market Access

Create your alert
to follow the executive moves at Otsuka Pharma Germany.

Otsuka Holdings has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Otsuka Pharma Germany

Social media about Otsuka Pharma Germany

• Otsuka Pharma Germany on Wikipedia, Google News & Yahoo Finance
• Otsuka Pharma Germany on LinkedIn, X (Twitter) & YouTube